Evidence map›Paper›PMID 26350674›Full record

ArticleMolecular biotechnology2015

End Joining-Mediated Gene Expression in Mammalian Cells Using PCR-Amplified DNA Constructs that Contain Terminator in Front of Promoter.

Mikiko Nakamura, Ayako Suzuki, Junko Akada, Keisuke Tomiyoshi, Hisashi Hoshida, Rinji Akada

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biotechnology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mikiko NakamuraInnovation Center, Yamaguchi University, Tokiwadai, Ube, 755-8611, Japan. nakamura@crc.yamaguchi-u.ac.jp.
Ayako SuzukiDepartment of Applied Molecular Bioscience, Graduate School of Medicine, Yamaguchi University, Tokiwadai, Ube, 755-8611, Japan.
Junko AkadaInnovation Center, Yamaguchi University, Tokiwadai, Ube, 755-8611, Japan.
Keisuke TomiyoshiDepartment of Applied Chemistry, Faculty of Engineering, Yamaguchi University, Tokiwadai, Ube, 755-8611, Japan.
Hisashi HoshidaDepartment of Applied Molecular Bioscience, Graduate School of Medicine, Yamaguchi University, Tokiwadai, Ube, 755-8611, Japan.
Rinji AkadaDepartment of Applied Molecular Bioscience, Graduate School of Medicine, Yamaguchi University, Tokiwadai, Ube, 755-8611, Japan. rinji@yamaguchi-u.ac.jp.
Yamaguchi University · JPTokiwa Park · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mammalian gene expression constructs are generally prepared in a plasmid vector, in which a promoter and terminator are located upstream and downstream of a protein-coding sequence, respectively. In this study, we found that front terminator constructs-DNA constructs containing a terminator upstream of a promoter rather than downstream of a coding region-could sufficiently express proteins as a result of end joining of the introduced DNA fragment. By taking advantage of front terminator constructs, FLAG substitutions, and deletions were generated using mutagenesis primers to identify amino acids specifically recognized by commercial FLAG antibodies. A minimal epitope sequence for polyclonal FLAG antibody recognition was also identified. In addition, we analyzed the sequence of a C-terminal Ser-Lys-Leu peroxisome localization signal, and identified the key residues necessary for peroxisome targeting. Moreover, front terminator constructs of hepatitis B surface antigen were used for deletion analysis, leading to the identification of regions required for the particle formation. Collectively, these results indicate that front terminator constructs allow for easy manipulations of C-terminal protein-coding sequences, and suggest that direct gene expression with PCR-amplified DNA is useful for high-throughput protein analysis in mammalian cells.

Indexed as

Gene Expression RegulationNucleic Acid Amplification TechniquesPromoter Regions, GeneticTerminator Regions, GeneticDNA FragmentationDNA PrimersHEK293 CellsHeLa CellsHepatitis B Surface AntigensHumansNuclear Localization SignalsOligopeptidesPeroxisomesPolymerase Chain ReactionSequence Analysis, DNASequence DeletionDNA PrimersHepatitis B Surface AntigensNuclear Localization SignalsOligopeptidesseryl-lysyl-leucineFLAG-tagGene expressionMutationNon-homologous end joining (NHEJ)Peroxisome localization signal sequencePolymerase chain reaction (PCR)Transcriptional terminatorTransfection

Identifiers

PMID26350674
OpenAlexW1473738730

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.